Samira Rasaneh

Statistics

Publications

Citations

202

H-Index

Active since

2009

Affiliations

Nuclear Science and Technology Research Institute(Current)

Atomic Energy Organization of Iran

Tarbiat Modares University

Sina Hospital

Noor Eye Hospital

Samira Rasaneh is an author at Nuclear Science and Technology Research Institute specializing in medicine, oncology, and targeted radionuclide therapy.

ORCID

Publications per year

2009–2015

Publications

Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer

Samira Rasaneh, Hossein Rajabi, M. H. Babaei et al. · Nuclear Medicine and Biology · 2009 · 74 citations

Medicine, Oncology, Pharmacology +14

177Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer

Samira Rasaneh, Hossein Rajabi, M. H. Babaei et al. · Nuclear Medicine and Biology · 2010 · 46 citations

Medicine, Molecular Pharmaceutics, Oncology +16

Toxicity of trastuzumab labeled 177Lu on MCF7 and SKBr3 cell lines

Samira Rasaneh, Hossein Rajabi, M. H. Babaei et al. · Applied Radiation and Isotopes · 2010 · 24 citations

Medicine, Oncology, Pharmacology +11

MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticles

Samira Rasaneh, Hossein Rajabi, M. H. Babaei et al. · Journal of Nanoparticle Research · 2010 · 16 citations

Medicine, Biomedical Engineering, Molecular Biology +17

Synthesis and biodistribution studiesof <sup>177</sup>Lu‐trastuzumab as a therapeutic agent in the breast cancer mice model

Samira Rasaneh, Hossein Rajabi, M. H. Babaei et al. · Journal of Labelled Compounds and Radiopharmaceuticals · 2010 · 16 citations

Medicine, Oncology, Pharmacology +17

1–5 of 7